Skip to content

Peptides for Immune Health

PeptidespeptideEarly stage

Availability Not yet prescribable · sold for research use only

What it is

This family covers peptides used for immune resilience and recovery, led by thymosin alpha-1, a thymic peptide involved in T-cell maturation, alongside LL-37, an antimicrobial host-defense peptide. Both act on different parts of a system that has to defend, calm down, and avoid attacking the wrong target at once.

Why people take it

Interest usually follows repeated illness, a slow rebound from a bug, a heavy stretch of stress or travel, or a clinic conversation about immune aging. People want fewer prolonged setbacks and a steadier baseline, not a vague promise of never getting sick.

How it's delivered

These are clinic-led injectable protocols, typically prescribed after a documented illness pattern or as part of a broader medical workup that already includes labs. A serious plan checks infection, autoimmune, and medication history before dosing, and sets a defined duration and follow-up point.

Where the evidence stands

Thymosin alpha-1 has the deepest clinical history here, studied across viral infection, vaccine response, and inflammatory contexts, including mixed COVID-19 and lung-infection results depending on severity and population. LL-37 is biologically active in host defense and immune signaling, but consumer protocols sit well ahead of direct outcome data. Neither supports a broad claim that healthy people need an immune peptide.

Estimated cost

  • No approved or lawfully compounded product, so no reference price for thymosin alpha-1 or LL-37
  • Not covered by insurance

Who offers it

We don't list providers for these peptides. None is an approved product, and we haven't verified any provider against the conditions of HHS's draft October 2026 interim compounding policy, which covers KPV.

Go deeper

The full guide, Peptides for Immune Health, covers thymic and antimicrobial peptide biology and where medical context changes the calculus. Thymosin alpha-1 and LL-37 have their own entries in the peptide database.

Longevity.io is for educational purposes only and is not medical advice. Whether an immune peptide belongs in your plan is a conversation for a clinician who knows your medical history. Confirm eligibility, product source, and pricing directly with any provider.

Your Longevity Blueprint

Build your starting plan.

A few short questions, about two minutes. The Blueprint recommends where to start and explains why.

Build my Blueprint